Le Lézard
Classified in: Health
Subjects: PDT, FDA

ARKRAY launches ADAMStm A1c HA-8180V System for hemoglobin A1c testing


EDINA, Minn., Sept. 18, 2017 /PRNewswire/ -- U.S. ARKRAY, Inc. (ARKRAY) announces the launch of the ADAMStm A1c HA-8180V System for hemoglobin A1c testing. The system obtained FDA 510(k) clearance as an aid in the diagnosis and monitoring of individuals with diabetes.

ADAMS A1c HA-8180V

The fully automated analyzer utilizes gold standard HPLC technology. Providing superior precision with CV's of one percent or lower offers clinicians confidence diagnosing and treating diabetes.

"We are excited to bring this technology to the U.S. market. The ADAMS A1c HA-8180V builds on proven expertise. The ADAMS brand has been used globally for decades. ARKRAY introduced the first fully automated HPLC HbA1c analyzer in 1981," said Shane Hawes, General Manager ARKRAY.

The system is simple to operate and generates results in ninety seconds. Calibration and maintenance are minimized with the integrated column and pre-filter. Hands-on time is reduced with primary tube cap-piercing sampling and no sample pre-treatment.

Early detection and treatment of diabetes can decrease the risk of developing long-term complications. The ADAMS A1c HA-8180V improves outcomes generating the quality results required to assess patient care.

U.S. ARKRAY, Inc. is a wholly owned subsidiary of ARKRAY, Inc. of Kyoto, Japan. ARKRAY, Inc. was founded in 1960 as Kyoto Daiichi Kagaku Inc. (KDK). ARKRAY is a global leader in urinalysis and continues to develop innovative diagnostic products including automated urinalysis and HbA1c systems. For more information, please visit www.arkrayusa.com.

 

SOURCE U.S. ARKRAY, Inc.


These press releases may also interest you

at 13:56
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patientsGastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare cancer that...

at 13:40
From 'the big one' to big relief for Adena Health heart attack patient
Jesse Patterson has always been more of a self-treatment type of guy when it comes to dealing with his health. So, when the normally active 73-year-old New Holland resident started getting short of breath and felt his lungs burning when he walked any...

at 13:12
Radians quarterly grassroots Tickets for Charity program empowers Midsouth nonprofits JIFF and The ARC Northwest Mississippi
Empowered by employee donations and matched by management contributions, Radians® quarterly Tickets for Charity (TFC) program champions local Memphis and Midsouth charities, offering crucial support for sustaining daily operations and expanding their...

at 13:07
Multi-talented Emmy® Award-Winning Host & Actress Tamera Mowry-Housley Set to Receive Trailblazer Award at A Pink Pump Affair
Multi-award-winning Civil Rights Attorney and Child Advocate, Areva Martin, in collaboration with the Special Needs Network (SNN), has revealed the distinguished honorees for the 16th Annual A Pink Pump Affair. This noteworthy charity event is...

at 13:05
Convergent Dental's "Solea User Group Meeting" Rebranded to "Solea Summit"
Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, proudly announces the rebranding of its annual customer event from the "Solea User Group Meeting" to the "Solea Summit." This update reflects the evolution of the event into the...

at 13:00
Laniado Hospital Kicks Off Major Campaign For Building New Rocket-Proof Emergency Building In Netanya
The Laniado Hospital in Netanya, Israel, is embarking on a crucial initiative to construct the country's first fully sheltered emergency care building. With the support of the Laniado Development Fund, this endeavor aims to enhance public healthcare...

More news about Health...


News published on and distributed by: